Up-date in the treatment of rapid cycling and other refractory bipolar disorders;Actualización en el tratamiento de pacientes cicladores rápidos y otros bipolares resistentes

Actas Espanolas de Psiquiatria

Volumn 31, Issue 3, 2003, Pages 149-155

  Fernández Pérez, Isabel ^a,b   De Frutos, M J ^a   Lujan E ^a   Ortiz Del Romero, J ^a  

^a Hospital Psiquiatrico de Madrid   (Spain)

^b NONE   (Spain)

Author keywords

Rapid cycling; Refractory bipolar disorder; Treatment

Indexed keywords

ADJUVANT; ANALGESIC AGENT; ANTIARRHYTHMIC AGENT; ANTICONVULSIVE AGENT; ANTIDEPRESSANT AGENT; CLOZAPINE; GABAPENTIN; LAMOTRIGINE; MEXILETINE; NEUROLEPTIC AGENT; OLANZAPINE; RISPERIDONE; STABILIZING AGENT; TOPIRAMATE; TRANQUILIZER;

AGRANULOCYTOSIS; ANXIETY DISORDER; ATAXIA; BEHAVIOR; BIPOLAR DISORDER; COCHRANE LIBRARY; CONCENTRATION LOSS; CONSTIPATION; CONVULSION; COORDINATION; DATA BASE; DEPRESSION; DRUG EFFECT; DRUG EFFICACY; EDEMA; FATIGUE; GASTROINTESTINAL DISEASE; GENERAL CONDITION IMPROVEMENT; HEADACHE; HUMAN; HYPERPROLACTINEMIA; HYPOTENSION; INFORMATION PROCESSING; INSOMNIA; LABORATORY; LITERATURE; MEDLINE; MIXED ANXIETY AND DEPRESSION; MONOTHERAPY; NAUSEA; PSYCHOSIS; PUBLICATION; RAPID CYCLING BIPOLAR DISORDER; RASH; REVIEW; SEDATION; SOMNOLENCE; STEVENS JOHNSON SYNDROME; TACHYCARDIA; TREMOR; VERTIGO;

ANTIPSYCHOTIC AGENTS; BIPOLAR DISORDER; HUMANS; TREATMENT OUTCOME;

EID: 0042066726     PISSN: 11399287     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Review

References (36)

1. Coryell W, Endicott J, Keller M. Rapid cycling affective disorder. Demographics, diagnosis, family history, and course. Arch Gen Psychiatry 1992;49:126-31.
2. Tondo L, Baldessarini RJ. Rapid cycling in women and men with bipolar maniac-depressive disorders. Am J Psychiatry 1998;155:1434-6.
3. Peet M. Induction of mania with selective serotonin re-uptake inhibitors and tricyclic antidepressants Br J Psychiatry 1994;164:549-50.
4. Calabrese JR, Woyshville MJ. A medication algorythm for the treatment of bipolar rapid cycling. J Clin Psychiatry 1995; 56(Suppl 3):11-18.
5. Kusumakar V, Yatham L, Kutcher S. Topiramato en el tratamiento de una muestra de mujeres con trastomo bipolar refractario (cicladoras rápidas). American Psychiatry Association (APA), Washington, 15-20 May 1999.
6. Plon L, Maguire G, Singh P. Topiramato en el tratamiento del trastorno bipolar refractario. International Psychogeriatric Association (IPA), Vancouver, 15-20 August 1999.
7. Vieta E, Gilabert A, Rodríguez A, García-Castrillón A, Luna MJ, Arrufat F, et al. Topiramato como tratamiento coadyuvante en el tratamiento bipolar refractario. International Psychogeriatric Association (IPA), Vancouver, 15-20 August 1999.
8. Vieta E, Gilabert A, Rodríguez A, García-Castrillón A, Luna MJ, Arrufat F, et al. Efectiveness and safety of topiramate in treatment-resistant bipolar disorder. Actas Esp Psiquiatr 2001;29:148-52.
9. Roy Chengappa KN, Rathore D, Levine J, Atzert R, Solai L, Parepally H. Topiramato en el trastorno bipolar. Hamburg: World Psychiatric Association, 6-11 August 1999.
10. Roy Chengappa KN, Rathore D, Levine J, Atzert R, Solai L, Parepally H. Topiramate as adjunctive treatment in bipolar disorder. Congreso Monográfico sobre Trastorno del Humor; p. 6.036.
11. Sachs G, Sambur M, Demopulos C, Ghaemi S. Topiramato en el tratamiento del trastorno bipolar refractario. London: European College of Neuropsychophamacology, 1999; p. 21-5.
12. Hussain MZ, Zubaida A. Treatment of bipolar depression with topiramate. London: European College of Neuropsychopharmacology, 1999; p. 21-5.
13. Grunze HC, Normann C, Langosch J, Schaefer M, Amann B, Sterr A, et al. Antimanic efficacy of topiramate in 11 patients in a open trial with an on-off-on desing. J Clin Psychiatry 2001;62:464-8.
14. Vieta E, Gilabert A, et al. Efectividad y seguridad del topiramato en el trastorno bipolar resistente. Actas Esp Psiquiatr 2001;29:148-52.
15. Vieta E, Nieto E, Martínez-Arán A, Benabarre A, Colom F, Reinares M, et al. Resultados de la administración de gabapentina como terapia coadyuvante en el trastomo bipolar. Psiquiatr Biol 1999;6:202-7.
16. Botts SR, Raskind J. Gabapentin and lamotrigine in bipolar disorder. Am J Health-Syst Pharm 1999;56:1939-44.
17. Calabrese JR, Shelton MD, Bowden CL, Rapport DJ, Suppes T, Shirley ER, et al. Bipolar rapid cycling: focus on depression as its Hallmark. J Clin Psychiatry 2001;62(Suppl 14): 34-41.
18. Aftshuler LL, Keck PE Jr, McElroy SL, Suppes T, Brown ES, Denicoff K, et al. Gabapentin in the acute treatment of refractory bipolar disorder. Bipolar disorders 1999;1:61-5.
19. Sokolski KN, Green C, Maris DE, DeMet EM. Gábapentin as an adjunct to standard mood stabilizers in outpatients with mixed bipolar symptomatology. Ann Clin Psychiatry 1999;11:217-22.
20. Gotor P. Los hijos del litio, la gabapentina a examen. Actualidades en Psiquiatría.
21. Young LT, Robb JC, Hasey GM, MacQueen GM, Patelis Siotis I, Marriott M, et al. Gabapentin as an adjuntive treatment in bipolar disorder. J Affect Disord 1999;55:73-7.
22. Schaffer A, Levitt A, Joffe R. Mexiletine in treatment-resistant bipolar disorder. J Affect Disord 2000;57:249-53.
23. Calabrese JR, Suppes T, Bowden CL, Sachs GS, Swann AC, McElroy SL, et al. A double-blind, placebo-controlled, prophylaxis study of lamotrigine in rapid-cycling bipolar disorder. Lamictal 614 Study Group. J Clin Psychiatry 2000; 61:841-50.
24. Walden J, Schaerer L, Schloesser S, Grunze H. An open longitudinal study of patients with bipolar rapid cycling treated with lithium or lamotrigine for mood stabilization. Bipolar Disord 2000;2:336-9.
25. Bowden CL, Lecrubier Y, Bauer M, Goodwin G, Greil W, Sachs G, et al. Maintenance therapies for classic and other forms of bipolar disorder. J Affect Disord 2000;59 (Suppl 1): S57-S67.
26. Goodwin FK. Anticonvulsivant therapy and suicide risk in affective disorders. J Clin Psychiatry 1999;60(Suppl 2): 89-93.
27. Hilty DM, Brady KT, Hales RE. A review of bipolar disorder among adults. Psychiatr Serv 1999;50:201-13.
28. Ghaemi S, Goodwin F. Use of atypical antipsychotic agents in bipolar and schizoaffective disorders; review of the empirical literature. J Clin Psychopharmacol 1999;19(4):354-60.
29. Bauer MS, Callahan AM, Jampala C, Petty F, Sajatovic M, Schaefer V, et al. Clinical practice guidelines for bipolar disorder from the Department of Veterans Affairs. J Clin Psychiatry 1999;60:9-21.
30. Montgomery SA, Keck PE. First International Exchange on Bipolar Disorder. J Affect Disord 2000;59:S81-8.
31. a ed. Editorial Intermédica. p. 109.
32. Montes Rodríguez JM, Ibáñez Cuadrado J, Saiz Ruiz J. Terapias combinadas con neurolépticos en el transcurso del trastorno bipolar. DD y racionalización del tratamiento psicofarmacológico. Madrid: Aula Médica, 2001; p. 183.
33. Vieta E, Gasto C. Trastornos bipolares. Barcelona: Springer Verlag Ibérica, 1997.
34. González Pinto A, Gutiérrez MY, Ezcurra J. Trastorno bipolar Madrid: Aula Médica, 1999.
35. Cámara Teruel JM, Dualde Beltrán F. Manual de Psicofarmacoterapia. Editorial You & Us, S.A., 2001.
36. Stahl SM. Psicofarmacología esencial de la depresión y el trastorno bipolar. Madrid: Editorial Panamericana, 2001.